LFCR
Price
$5.82
Change
+$0.10 (+1.75%)
Updated
Apr 11 closing price
Capitalization
176.87M
137 days until earnings call
LNTH
Price
$102.00
Change
+$3.49 (+3.54%)
Updated
Apr 11 closing price
Capitalization
4.27B
19 days until earnings call
Ad is loading...

LFCR vs LNTH

Header iconLFCR vs LNTH Comparison
Open Charts LFCR vs LNTHBanner chart's image
Lifecore Biomedical
Price$5.82
Change+$0.10 (+1.75%)
Volume$236.72K
Capitalization176.87M
Lantheus Holdings
Price$102.00
Change+$3.49 (+3.54%)
Volume$732.12K
Capitalization4.27B
LFCR vs LNTH Comparison Chart
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. LNTH commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a StrongBuy and LNTH is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (LFCR: $5.82 vs. LNTH: $102.00)
Brand notoriety: LFCR and LNTH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LFCR: 103% vs. LNTH: 76%
Market capitalization -- LFCR: $176.87M vs. LNTH: $4.27B
LFCR [@Pharmaceuticals: Other] is valued at $176.87M. LNTH’s [@Pharmaceuticals: Other] market capitalization is $4.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileLNTH’s FA Score has 3 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • LNTH’s FA Score: 3 green, 2 red.
According to our system of comparison, LNTH is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 6 TA indicator(s) are bullish while LNTH’s TA Score has 6 bullish TA indicator(s).

  • LFCR’s TA Score: 6 bullish, 4 bearish.
  • LNTH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both LFCR and LNTH are a good buy in the short-term.

Price Growth

LFCR (@Pharmaceuticals: Other) experienced а +10.02% price change this week, while LNTH (@Pharmaceuticals: Other) price change was +12.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.37%. For the same industry, the average monthly price growth was -3.00%, and the average quarterly price growth was -12.91%.

Reported Earning Dates

LFCR is expected to report earnings on Aug 27, 2025.

LNTH is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.37% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNTH($4.27B) has a higher market cap than LFCR($177M). LNTH YTD gains are higher at: 14.017 vs. LFCR (-21.669). LNTH has higher annual earnings (EBITDA): 491M vs. LFCR (-22.64M). LNTH has more cash in the bank: 714M vs. LFCR (4.22M). LFCR has less debt than LNTH: LFCR (157M) vs LNTH (617M). LNTH has higher revenues than LFCR: LNTH (1.3B) vs LFCR (188M).
LFCRLNTHLFCR / LNTH
Capitalization177M4.27B4%
EBITDA-22.64M491M-5%
Gain YTD-21.66914.017-155%
P/E RatioN/A12.93-
Revenue188M1.3B15%
Total Cash4.22M714M1%
Total Debt157M617M25%
FUNDAMENTALS RATINGS
LFCR vs LNTH: Fundamental Ratings
LFCR
LNTH
OUTLOOK RATING
1..100
7766
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10016
SMR RATING
1..100
9730
PRICE GROWTH RATING
1..100
5546
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LNTH's Valuation (65) in the Medical Specialties industry is in the same range as LFCR (96) in the Industrial Specialties industry. This means that LNTH’s stock grew similarly to LFCR’s over the last 12 months.

LNTH's Profit vs Risk Rating (16) in the Medical Specialties industry is significantly better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that LNTH’s stock grew significantly faster than LFCR’s over the last 12 months.

LNTH's SMR Rating (30) in the Medical Specialties industry is significantly better than the same rating for LFCR (97) in the Industrial Specialties industry. This means that LNTH’s stock grew significantly faster than LFCR’s over the last 12 months.

LNTH's Price Growth Rating (46) in the Medical Specialties industry is in the same range as LFCR (55) in the Industrial Specialties industry. This means that LNTH’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (4) in the Industrial Specialties industry is in the same range as LNTH (9) in the Medical Specialties industry. This means that LFCR’s stock grew similarly to LNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRLNTH
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 9 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
66%
View a ticker or compare two or three
Ad is loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGRFX25.36N/A
N/A
Macquarie Mid Cap Growth R6
UIVPX10.89N/A
N/A
MFS Intrinsic Value R3
ASQIX13.72N/A
N/A
American Century Small Company Inv
QCSGX16.72N/A
N/A
Federated Hermes MDT Small Cap Growth C
FUGCX41.41N/A
N/A
Fidelity Advisor Utilities C

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+1.84%
SHPH - LFCR
31%
Poorly correlated
-11.81%
CGC - LFCR
28%
Poorly correlated
+9.43%
TLRY - LFCR
27%
Poorly correlated
-3.56%
GLASF - LFCR
26%
Poorly correlated
+0.55%
ACB - LFCR
26%
Poorly correlated
+4.14%
More

LNTH and

Correlation & Price change

A.I.dvisor tells us that LNTH and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
+3.54%
ACET - LNTH
32%
Poorly correlated
+20.11%
SNDL - LNTH
26%
Poorly correlated
-0.73%
LFCR - LNTH
24%
Poorly correlated
+1.84%
ORGO - LNTH
24%
Poorly correlated
+13.60%
BFRI - LNTH
23%
Poorly correlated
+3.83%
More